Newsletter | July 15, 2024

07.15.24 -- How The Right Operating Model For EU MDR Compliance Can Support A Global Footprint

FEATURED EDITORIAL

How The Right Operating Model For EU MDR Compliance Can Support A Global Footprint

EU MDR has raised the bar compared to other jurisdictions in areas such as stronger emphasis on collecting pre- and post-market data. If you align your operating model for EU compliance, you'll be in a better position to enter other markets.

INDUSTRY INSIGHTS

Delivering On GLP-1 Demand: Combining Device And Supply Strategy

Meeting the demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions offer customization, streamlined manufacturing, and formulation compatibility.

Off-The-Shelf Vs. Novel Devices: Selecting A Drug Delivery System

Whether bringing a novel therapy to market or altering current devices, companies must determine the best selection for administration without impacting drug efficacy, quality, and safety.

A Taste Masked And Easily Swallowed Malaria Drug For Elderly Patients

Dysphagia impacts treatment compliance and disproportionately affects the elderly. Learn how microencapsulation enabled formulation of a water-soluble powder drives patient adherence.

Improving Safety And Efficacy With Charged Variant Characterization

Discover how a CDMO with extensive experience in protein variant characterization, CQA analytics, and patient-centric product development can ensure the safety and efficacy of your biotherapeutic.

Scaling Up A Revolutionary Amorphous Solid Dispersion Platform

Process parameter and quality attribute relationships, including those for typical pre and post ASD unit operations, will be explored in the context of real-world examples.

SOLUTIONS

Global Experts In Nanotechnology And Drug Particle Engineering

Real World Dosing Solutions For Patients

Injecting Sustainability Into Drug Delivery Device Design